Drug Profile
WIN 33377
Alternative Names: SR 233377Latest Information Update: 18 Aug 1999
Price :
$50
*
At a glance
- Originator Sanofi Winthrop
- Class Antineoplastics
- Mechanism of Action Alkylating agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Solid tumours